vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Legacy Housing Corp (LEGH). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $25.5M, roughly 1.9× Legacy Housing Corp). Legacy Housing Corp runs the higher net margin — 32.2% vs -4.8%, a 36.9% gap on every dollar of revenue. On growth, Legacy Housing Corp posted the faster year-over-year revenue change (-30.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $15.7M). Over the past eight quarters, Legacy Housing Corp's revenue compounded faster (-9.1% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.
IRWD vs LEGH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $25.5M |
| Net Profit | $-2.3M | $8.2M |
| Gross Margin | — | 26.4% |
| Operating Margin | 14.3% | 40.4% |
| Net Margin | -4.8% | 32.2% |
| Revenue YoY | -47.3% | -30.6% |
| Net Profit YoY | -200.9% | -43.5% |
| EPS (diluted) | $0.01 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $25.5M | ||
| Q3 25 | $122.1M | $28.8M | ||
| Q2 25 | $85.2M | $38.4M | ||
| Q1 25 | $41.1M | $24.3M | ||
| Q4 24 | $90.5M | $36.7M | ||
| Q3 24 | $91.6M | $30.2M | ||
| Q2 24 | $94.4M | $31.7M | ||
| Q1 24 | $74.9M | $30.8M |
| Q4 25 | $-2.3M | $8.2M | ||
| Q3 25 | $40.1M | $8.6M | ||
| Q2 25 | $23.6M | $14.7M | ||
| Q1 25 | $-37.4M | $10.3M | ||
| Q4 24 | $2.3M | $14.5M | ||
| Q3 24 | $3.6M | $15.8M | ||
| Q2 24 | $-860.0K | $16.2M | ||
| Q1 24 | $-4.2M | $15.1M |
| Q4 25 | — | 26.4% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | — | 32.4% | ||
| Q1 25 | — | 29.2% | ||
| Q4 24 | — | 27.3% | ||
| Q3 24 | — | 29.2% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 33.6% |
| Q4 25 | 14.3% | 40.4% | ||
| Q3 25 | 61.8% | 33.7% | ||
| Q2 25 | 53.2% | 43.8% | ||
| Q1 25 | -70.7% | 47.7% | ||
| Q4 24 | 34.8% | 42.3% | ||
| Q3 24 | 28.0% | 50.8% | ||
| Q2 24 | 26.5% | 50.6% | ||
| Q1 24 | 14.7% | 54.3% |
| Q4 25 | -4.8% | 32.2% | ||
| Q3 25 | 32.8% | 30.0% | ||
| Q2 25 | 27.7% | 38.3% | ||
| Q1 25 | -90.9% | 42.3% | ||
| Q4 24 | 2.5% | 39.5% | ||
| Q3 24 | 4.0% | 52.4% | ||
| Q2 24 | -0.9% | 51.1% | ||
| Q1 24 | -5.6% | 49.1% |
| Q4 25 | $0.01 | $0.38 | ||
| Q3 25 | $0.23 | $0.35 | ||
| Q2 25 | $0.14 | $0.60 | ||
| Q1 25 | $-0.23 | $0.41 | ||
| Q4 24 | $0.03 | $0.59 | ||
| Q3 24 | $0.02 | $0.64 | ||
| Q2 24 | $-0.01 | $0.65 | ||
| Q1 24 | $-0.03 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $8.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $528.6M |
| Total Assets | $396.9M | $580.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $8.5M | ||
| Q3 25 | $140.4M | $13.6M | ||
| Q2 25 | $92.9M | $2.6M | ||
| Q1 25 | $108.5M | $3.4M | ||
| Q4 24 | $88.6M | $1.1M | ||
| Q3 24 | $88.2M | $570.0K | ||
| Q2 24 | $105.5M | $60.0K | ||
| Q1 24 | $121.5M | $621.0K |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $528.6M | ||
| Q3 25 | $-264.2M | $521.6M | ||
| Q2 25 | $-308.2M | $512.8M | ||
| Q1 25 | $-334.1M | $503.7M | ||
| Q4 24 | $-301.3M | $494.0M | ||
| Q3 24 | $-311.3M | $479.3M | ||
| Q2 24 | $-321.7M | $463.2M | ||
| Q1 24 | $-330.5M | $450.4M |
| Q4 25 | $396.9M | $580.3M | ||
| Q3 25 | $396.1M | $557.9M | ||
| Q2 25 | $342.9M | $552.0M | ||
| Q1 25 | $327.2M | $544.6M | ||
| Q4 24 | $350.9M | $534.2M | ||
| Q3 24 | $389.5M | $521.4M | ||
| Q2 24 | $395.6M | $514.9M | ||
| Q1 24 | $438.8M | $510.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $19.0M |
| Free Cash FlowOCF − Capex | $74.6M | $15.7M |
| FCF MarginFCF / Revenue | 156.3% | 61.6% |
| Capex IntensityCapex / Revenue | 0.0% | 13.1% |
| Cash ConversionOCF / Net Profit | — | 2.32× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $28.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $19.0M | ||
| Q3 25 | $47.6M | $7.2M | ||
| Q2 25 | $-15.1M | $6.1M | ||
| Q1 25 | $20.0M | $4.9M | ||
| Q4 24 | $15.2M | $7.9M | ||
| Q3 24 | $9.9M | $13.8M | ||
| Q2 24 | $33.5M | $3.5M | ||
| Q1 24 | $45.0M | $10.8M |
| Q4 25 | $74.6M | $15.7M | ||
| Q3 25 | $47.6M | $5.1M | ||
| Q2 25 | $-15.1M | $3.7M | ||
| Q1 25 | $19.9M | $3.6M | ||
| Q4 24 | — | $6.0M | ||
| Q3 24 | $9.9M | $9.1M | ||
| Q2 24 | $33.4M | $1.7M | ||
| Q1 24 | $44.9M | $9.9M |
| Q4 25 | 156.3% | 61.6% | ||
| Q3 25 | 39.0% | 17.8% | ||
| Q2 25 | -17.7% | 9.6% | ||
| Q1 25 | 48.4% | 15.0% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | 10.8% | 30.2% | ||
| Q2 24 | 35.4% | 5.4% | ||
| Q1 24 | 60.0% | 32.2% |
| Q4 25 | 0.0% | 13.1% | ||
| Q3 25 | 0.0% | 7.1% | ||
| Q2 25 | 0.0% | 6.2% | ||
| Q1 25 | 0.1% | 5.2% | ||
| Q4 24 | 0.0% | 5.1% | ||
| Q3 24 | 0.0% | 15.6% | ||
| Q2 24 | 0.1% | 5.5% | ||
| Q1 24 | 0.1% | 2.8% |
| Q4 25 | — | 2.32× | ||
| Q3 25 | 1.19× | 0.83× | ||
| Q2 25 | -0.64× | 0.41× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | 6.74× | 0.54× | ||
| Q3 24 | 2.71× | 0.88× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
LEGH
| Commercial Sales | $8.6M | 34% |
| Retail Store Sales | $6.0M | 24% |
| Inventory Finance Sales | $5.0M | 20% |
| Direct Sales | $4.4M | 17% |
| Other | $1.5M | 6% |
